Atlas Trials

Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD

Clinical trial NCT05766449 · RECRUITING

Trial details

NCT number
NCT05766449
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status
RECRUITING
Study type
OBSERVATIONAL
Chronic Hepatitis bNon-alcoholic Fatty Liver Disease
Start date
2022-06-01
Primary completion
2027-03-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.